🔗 Share this article

A shadow market for unlicensed weight-loss medications is being driven by social media fitness personalities and sellers on messaging platforms, based on recent findings.

Experimental Drug Gaining Traction Via Social Media

Retatrutide, which is still in research studies, is being promoted by social media influencers for its alleged weight-reducing effects. Followers are urged to contact these accounts directly for supplier links, while also obtaining promotional offers.

Active Trade on Messaging Platforms

Separately, a flourishing market exists on Telegram, where groups with numerous of participants share “before and after” photos, administration instructions and assertions of rapid UK delivery. Vendors market the substance there before directing customers to WhatsApp for purchases.

Understanding Retatrutide

Retatrutide is an investigational injection developed by US drugmaker Eli Lilly. The drug affects three intestinal hormones – GLP-1, GIP and glucagon. Early trials suggest it could assist individuals reduce up to a quarter of their total weight. Referred to as the “triple G”, the substance is being promoted online as the next Ozempic.

Medical Professionals Express Concerns

However, physicians and chemists have cautions that the distribution of what is still an unapproved drug in the UK is a cause for concern and could lead to individuals injecting substances of unknown origin.

Several professionals said the popularity for retatrutide could be connected to the rising cost of licensed slimming treatments such as Mounjaro.

Legal Position and Implementation

Selling the unapproved drug on TikTok or messaging apps is prohibited in the United Kingdom, as it is an unapproved drug that cannot be marketed or distributed for personal consumption under the Human Medicines Regulations 2012.

Some influencers attempt to circumvent the rules by referring to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled drug, but promotion and distribution can still violate medicines, marketing, and customer laws, risking penalties, prosecution or prison.

Service Reaction and Material Elimination

According to the social media company, the platform has taken down violative material and prohibited related keywords and query recommendations. The organization said it was committed to keeping the service safe and investing in enhancing enforcement strategies.

Digital Marketplace Activities

Investigations also found communities with up to nine thousand participants marketing the experimental drug using Telegram's built-in discovery tool, which operates like a online catalog. Typing “retatrutide” instantly displays groups with thousands of members, filled with images of weight loss, positive testimonials and step-by-step instructions for preparing or injecting at home.

After minutes of entering one group, a vendor shared WhatsApp details, where most transactions take place. The seller provided an instruction manual and guaranteed shipping within two days. When questioned whether the product was authentic, one seller said: “You can’t be sure.” Another shared a image of a supposed testing documentation. None asked about body mass, medical conditions or previous experience.

Product Details and Pricing

Within these communities, messages display dark colored packages with Royal Mail labels, claiming to include new batches. One message read: “It took eight of us to load them this morning.”

Buyers can choose between powder vials, mixed at home with sterile water, or ready-to-use injectors usually priced at 160 pounds for 20 milligrams. When asked how much time a injector should be used, sellers give conflicting responses varying between a few weeks to “depends on your body”.

Service Moderation and Safety Measures

A representative for the messaging service said it regularly monitored dangerous content on its service including material that promoted the “misuse of controlled medications”. The organization noted that it eliminated “millions of pieces of harmful content each day”.

Healthcare Expert Cautions

“People are injecting materials they can’t verify. Although the research behind this drug is valid, these digital products may not contain what they claim,” stated a pharmacy expert, the head of pharmaceutical services at Chemist4U.

A medical professional of an online medical service linked the increase in interest to recent price rises for authorized weight-loss drugs such as Mounjaro. “With prices increasing, patients are using social media. But counterfeit treatments are highly risky. You cannot know what’s inside or whether the environment they were made in was sterile,” she said.

Her team has already encountered individuals harmed by personal administration from unconfirmed suppliers. “We recognize the disappointment, but buying from Telegram or WhatsApp is taking chances with your well-being,” said the doctor. “These materials could be impure or improperly measured.”

Producer Statement

A spokesperson from Eli Lilly stated retatrutide was in third stage research studies and had not been evaluated or approved by any regulatory agency anywhere in the world. “Therefore at this time no one can market [it] for human use,” they explained, noting that any item “misleadingly claiming itself as a Lilly experimental product not yet approved … may expose patients to possibly serious medical dangers”.